Skip to main content
. 2016 Jan 18;8(2):92–106. doi: 10.4254/wjh.v8.i2.92

Figure 2.

Figure 2

Direct acting antiviral agents. Modified from Alexopoulou et al[121]. Interferon-based combination treatment for chronic hepatitis C in the era of direct acting antivirals. Annals of Gastroenterology 2015; 28: 55-65. NPIs: Nucleoside polymerase inhibitors; NNPIs: Non-nucleoside polymerase inhibitors; DAA: Direct acting antiviral.